A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants

NCT07055321 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: ETH47
DRUG: ETH47
DRUG: ETH47
DRUG: ETH47
DRUG: ETH47
DRUG: ETH47
DRUG: ETH47
DRUG: ETH47
DRUG: ETH47

Sponsor

Ethris GmbH